Mesenchymal Stem Cell Transplantation in Multiple Sclerosis

Tekijä Cohen, Jeffrey A.
Julkaistu 2013

Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis

Tekijä Subei, Adnan M., Cohen, Jeffrey A.
Julkaisussa CNS Drugs (2015)

Considerations in the development of generic disease therapies for multiple sclerosis

Tekijä Hua, Le H., Cohen, Jeffrey A.
Julkaisussa Neurol Clin Pract (2016)

Fingolimod

Tekijä Hyland, Megan H., Cohen, Jeffrey A.
Julkaisussa Neurol Clin Pract (2011)

Mesenchymal Stem Cell-derived Neural Progenitor Cells in Progressive Multiple Sclerosis: Great Expectations

Tekijä Baldassari, Laura E., Cohen, Jeffrey A.
Julkaisussa EBioMedicine (2018)

The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis

Tekijä Goldschmidt, Carolyn H., Cohen, Jeffrey A.
Julkaisussa Neurotherapeutics (2020)

Handbook of multiple sclerosis

Tekijä Cohen, Jeffrey A., Rae-Grant, Alexander.
Julkaistu 2012.

Abstract: Effect of Botulinum Toxin Injection Intervals on the Irreversibility of Targeted Muscle Paralysis: An Electromyographic Study

Tekijä Boonipat, Thanapoom, Cohen, Jeffrey A., Stotland, Mitchell
Julkaisussa Plast Reconstr Surg Glob Open (2016)

Response of the multiple sclerosis community to COVID-19

Tekijä Ciccarelli, Olga, Cohen, Jeffrey A, Thompson, Alan
Julkaisussa Mult Scler (2020)

Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions

Tekijä Hyland, Megan, Bermel, Robert A., Cohen, Jeffrey A.
Julkaistu 2013

The first volume of MSJ-ETC

Tekijä Cohen, Jeffrey A, Kim, Ho Jin, Tintore, Mar
Julkaisussa Mult Scler J Exp Transl Clin (2016)

Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis

Tekijä Chaudhry, Burhan Z., Cohen, Jeffrey A., Conway, Devon S.
Julkaisussa Neurotherapeutics (2017)

Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead

Tekijä Conway, Devon S., Hua, Le H., Cohen, Jeffrey A.
Julkaisussa Neurotherapeutics (2017)

Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions

Tekijä Smith, Andrew L., Cohen, Jeffrey A., Hua, Le H.
Julkaisussa Neurotherapeutics (2017)

Follow-on glatiramer acetate

Tekijä Cohen, Jeffrey A., Wolf, Christian, Selmaj, Krzysztof, Arends, Roel
Julkaisussa eNeurologicalSci (2018)

Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero

Tekijä Smith, Andrew L, Cohen, Jeffrey A, Ontaneda, Daniel, Rensel, Mary
Julkaisussa Mult Scler J Exp Transl Clin (2019)

Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan

Tekijä Lane, Michael A., Renga, Vijay, Pachner, Andrew R., Cohen, Jeffrey A.
Julkaisussa Case Rep Neurol Med (2015)

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program

Tekijä Havrdova, Eva, Cohen, Jeffrey A, Horakova, Dana, Kovarova, Ivana, Meluzinova, Eva
Julkaisussa Ther Clin Risk Manag (2017)

Cell-based therapeutic strategies for multiple sclerosis

Tekijä Scolding, Neil J, Pasquini, Marcelo, Reingold, Stephen C, Cohen, Jeffrey A
Julkaisussa Brain (2017)

Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

Tekijä Cohen, Jeffrey A., Tenenbaum, Nadia, Bhatt, Alit, Zhang, Ying, Kappos, Ludwig
Julkaisussa Ther Adv Neurol Disord (2019)